microRNA profiling in paired human prostate cancer and benign prostate tissue
To determine the altered microRNA expression signature in human prostate cancer compared to benign prostate tissue. To determine the altered mRNA expression signatures upon overexrpession miR-31 in prostate cancer cells.
Provenance — who produced it, who reused it
Linked to 13 papers in the literature. Roles are inferred factual signals (who deposited the data vs who reused it), with counts — never a judgement about any author.
- Knowledge about the presence or absence of miRNA isoforms (isomi... 2017 · 225 cites
- MicroRNA Profiling in Prostate Cancer - The Diagnostic Potential... 2013 · 171 cites
- Automatic discovery of 100-miRNA signature for cancer classifica... 2019 · 86 cites
- Integrative Analysis of MicroRNA and Gene Interactions for Revea... 2020 · 74 cites
9 further papers cite this accession but reuse could not be confirmed.
Deep data QC
metadata only · no data-level QC for this typeStandardized, field-standard QC computed by touching the data — every metric states how it was obtained
No quantitative QC rubric exists for this data type yet, so it is deliberately left unscored — this is an honest "not applicable", not a poor rating.
measured = computed from the data · extrapolated/reported = derived or from the repository · dq-1.0 · provisional — verify independently
Scientific quality
Based on hands-on reproduction of the papers that use this dataset. A reproducible paper that stands on this data is positive evidence; a flagged one is a prompt to look closer — never a verdict on the dataset itself without the evidence.